The prospect of therapeutic antibody targeting IL-6 receptor

被引：0
|
作者：
Nishimoto, Norihiro [1 ]
机构：
[1] Osaka Univ, Grad Sch, Lab Immune Regulat, Suita, Osaka 5650871, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2008年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
下载
收藏
页码：27P / 27P
页数：1
相关论文
共 50 条
  • [31] ANTIBODY COCKTAIL IMMUNOTHERAPY FOR GLIOBLASTOMA BY DUAL TARGETING OF IL-6 AND CD40
    Yang, Fan
    Brem, Steven
    Fan, Yi
    NEURO-ONCOLOGY, 2021, 23 : 203 - 203
  • [32] IL-6 Receptor Antibody Preferentially Affects Tumors in the Repopulation Phase of Growth
    Sura, K.
    Galoforo, S.
    Buelow, K.
    Dabjan, M.
    Grills, I. S.
    Wilson, G. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E187 - E187
  • [33] Anti-interleukin 6 (IL-6) receptor antibody suppresses Castleman's disease like symptoms emerged in IL-6 transgenic mice
    Katsume, A
    Saito, H
    Yamada, Y
    Yorozu, K
    Ueda, O
    Akamatsu, K
    Nishimoto, N
    Kishimoto, T
    Yoshizaki, K
    Ohsugi, Y
    CYTOKINE, 2002, 20 (06) : 304 - 311
  • [34] The function of the soluble interleukin 6 (IL-6) receptor in vivo: Sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6
    Peters, M
    Jacobs, S
    Ehlers, M
    Vollmer, P
    Mullberg, J
    Wolf, E
    Brem, G
    zumBuschenfelde, KHM
    RoseJohn, S
    JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04): : 1399 - 1406
  • [35] Rational Effectiveness of an Anti-Mouse IL-6 Receptor Monoclonal Antibody in Chemotherapy Targeting Colon Cancer Stem Cells
    Jin, Ying
    Tsujii, Masahiko
    Kondo, Jumpei
    Hayashi, Yoshito
    Kato, Motohiko
    Akasaka, Tomofumi
    Inoue, Takuya
    Shiraishi, Eri
    Inoue, Takahiro
    Hiyama, Satoshi
    Tsujii, Yoshiki
    Maekawa, Akira
    Kawai, Shoichiro
    Fujinaga, Tetsuji
    Araki, Mamoru
    Shinzaki, Shinichiro
    Watabe, Kenji
    Nishida, Tsutomu
    Iijima, Hideki
    Takehara, Tetsuo
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (09) : 2017 - 2017
  • [36] SERUM-SOLUBLE INTERLEUKIN-6 (IL-6) RECEPTOR AND IL-6 SOLUBLE IL-6 RECEPTOR COMPLEX IN SYSTEMIC JUVENILE RHEUMATOID-ARTHRITIS
    DEBENEDETTI, F
    MASSA, M
    PIGNATTI, P
    ALBANI, S
    NOVICK, D
    MARTINI, A
    JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05): : 2114 - 2119
  • [37] In vivo targeting with monoclonal antibodies against gp130 but not IL-6 or IL-6 receptor blocks plasmacytoma cell growth completely
    Burger, R.
    Staudinger, M.
    Peipp, M.
    Wijdenes, J.
    Guenther, A.
    Gramatzki, M.
    ONKOLOGIE, 2013, 36 : 213 - 214
  • [38] Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody
    Kazuyuki Yoshizaki
    Norihiro Nishimoto
    Masahiro Mihara
    Tadamitsu Kishimoto
    Springer Seminars in Immunopathology, 1998, 20 : 247 - 259
  • [39] Anti-IL-6 receptor antibody treatment improves interstitial lung diseases in IL-6 transgenic mice
    Sugamata, Y
    Nakahara, H
    Katsume, A
    Sugimoto, M
    Yoshizaki, K
    Nishimoto, N
    JOURNAL OF LEUKOCYTE BIOLOGY, 2001, : 81 - 81
  • [40] Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody
    Yoshizaki, K
    Nishimoto, N
    Mihara, M
    Kishimoto, T
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1998, 20 (1-2): : 247 - 259
12345